The global cytidine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing incidence of chronic diseases such as cancer, acute leukaemia, and cerebrovascular diseases. According to the WHO, in 2019, around 6.6 million deaths were caused due to cerebrovascular diseases globally. Due to this increasing burden of the disease, it is expected to fuel the growth of the market during the forecast period.

Cytidine is used for the treatment of various chronic diseases which include managing neuropsychiatric deficits which are caused due to or are associated with cerebrovascular diseases. During the treatment of these diseases, cytidine is generally combined with uridine. Cytidine when administered intraperitoneal in combination with choline helps patients in improving their nerve regeneration and recovery of sciatic nerve injury. According to the recent paper published in Dovepress, nucleotides cytidine and uridine when combined with vitamin B-12 vs B-complex vitamins are effective in the treatment of low back pain. 

There are various cytidine analogues present that are used for the treatment of cancer such as KP-1461 is used as an anti-HIV agent, zebularine which is present in E.coli and an analogue of cytidine is currently being examined for the chemotherapy. Other drug therapies such as low dosage of azacitidine and its analogue decitabine have yielded good results against cancer by doing epigenetic demethylation.  Some of the key global players in the cytidine market include Teva Pharmaceuticals, Hospira, Mylan, Hisun, Lingnan, and many others.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Product type

o By Application

• Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Teva Pharmaceuticals, Hospira, Mylan, Hisun, Lingnan, and many others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global cytidine market by Segments

• By Product type

o Cytarabine

o Azacitidine

o Decitabine

• By Application

o Cancer therapy

o Acute Leukemia Therapy

o Cerebrovascular Diseases

Global cytidine market by Regions